The estimated Net Worth of Venture Partners Viii, Llca... is at least $42.3 Millón dollars as of 2 November 2018. Venture Llca owns over 75,000 units of Twist Bioscience Corp stock worth over $42,325,917 and over the last 6 years Venture sold TWST stock worth over $0.
Venture has made over 1 trades of the Twist Bioscience Corp stock since 2018, according to the Form 4 filled with the SEC. Most recently Venture bought 75,000 units of TWST stock worth $1,050,000 on 2 November 2018.
The largest trade Venture's ever made was buying 75,000 units of Twist Bioscience Corp stock on 2 November 2018 worth over $1,050,000. On average, Venture trades about 75,000 units every 0 days since 2018. As of 2 November 2018 Venture still owns at least 954,146 units of Twist Bioscience Corp stock.
You can see the complete history of Venture Llca stock trades at the bottom of the page.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell y Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: